SAGE Therapeutics IncNASDAQ:SAGE
- LAST PRICE5.3700
- TODAY'S CHANGE (%)-0.3600 (-6.2827%)
- Bid / Lots5.3400/ 2
- Ask / Lots5.4100/ 2
- Open / Previous Close5.8700 / 5.7300
- Day Range
- 52 Week Range
- Volume892,362
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAGE |
|---|---|---|
| 09:32 ET | 7733 | 5.74 |
| 09:33 ET | 800 | 5.725 |
| 09:35 ET | 2900 | 5.66 |
| 09:39 ET | 2857 | 5.615 |
| 09:42 ET | 4079 | 5.63 |
| 09:44 ET | 200 | 5.58 |
| 09:46 ET | 295 | 5.585 |
| 09:48 ET | 100 | 5.59 |
| 09:50 ET | 2800 | 5.59 |
| 09:51 ET | 200 | 5.56 |
| 09:53 ET | 3640 | 5.54 |
| 09:55 ET | 1200 | 5.52 |
| 09:57 ET | 7181 | 5.545 |
| 10:00 ET | 2758 | 5.55 |
| 10:02 ET | 561 | 5.51 |
| 10:04 ET | 11743 | 5.52 |
| 10:06 ET | 625 | 5.51 |
| 10:08 ET | 1201 | 5.47 |
| 10:09 ET | 4858 | 5.48 |
| 10:11 ET | 329 | 5.47 |
| 10:13 ET | 10115 | 5.49 |
| 10:15 ET | 300 | 5.495 |
| 10:18 ET | 1100 | 5.495 |
| 10:20 ET | 3716 | 5.5 |
| 10:22 ET | 13456 | 5.535 |
| 10:24 ET | 2360 | 5.52 |
| 10:26 ET | 3957 | 5.55 |
| 10:27 ET | 1118 | 5.54 |
| 10:29 ET | 4965 | 5.53 |
| 10:31 ET | 5380 | 5.51 |
| 10:33 ET | 4310 | 5.5099 |
| 10:36 ET | 3036 | 5.5 |
| 10:38 ET | 5255 | 5.52 |
| 10:40 ET | 300 | 5.52 |
| 10:42 ET | 300 | 5.52 |
| 10:44 ET | 2443 | 5.51 |
| 10:45 ET | 370 | 5.52 |
| 10:47 ET | 7678 | 5.59 |
| 10:49 ET | 200 | 5.58 |
| 10:51 ET | 3727 | 5.56 |
| 10:54 ET | 335 | 5.57 |
| 10:56 ET | 7242 | 5.59 |
| 10:58 ET | 792 | 5.57 |
| 11:00 ET | 1300 | 5.6 |
| 11:02 ET | 2191 | 5.6 |
| 11:03 ET | 3104 | 5.6 |
| 11:05 ET | 100 | 5.6081 |
| 11:07 ET | 463 | 5.6 |
| 11:09 ET | 1079 | 5.5901 |
| 11:12 ET | 4203 | 5.6 |
| 11:16 ET | 601 | 5.59 |
| 11:18 ET | 671 | 5.59 |
| 11:20 ET | 600 | 5.59 |
| 11:21 ET | 1245 | 5.58 |
| 11:23 ET | 600 | 5.57 |
| 11:25 ET | 700 | 5.57 |
| 11:27 ET | 7045 | 5.5675 |
| 11:30 ET | 300 | 5.56 |
| 11:32 ET | 350 | 5.5571 |
| 11:36 ET | 571 | 5.55 |
| 11:38 ET | 100 | 5.54 |
| 11:39 ET | 1300 | 5.52 |
| 11:41 ET | 5754 | 5.52 |
| 11:43 ET | 1832 | 5.52 |
| 11:45 ET | 1804 | 5.505 |
| 11:48 ET | 340 | 5.5 |
| 11:50 ET | 3000 | 5.505 |
| 11:52 ET | 1816 | 5.505 |
| 11:54 ET | 1688 | 5.505 |
| 11:56 ET | 1356 | 5.492 |
| 11:59 ET | 200 | 5.5 |
| 12:01 ET | 357 | 5.5 |
| 12:03 ET | 1000 | 5.505 |
| 12:06 ET | 2059 | 5.49 |
| 12:08 ET | 1499 | 5.5 |
| 12:10 ET | 3170 | 5.5116 |
| 12:14 ET | 600 | 5.5183 |
| 12:15 ET | 2092 | 5.5 |
| 12:17 ET | 957 | 5.5 |
| 12:19 ET | 3859 | 5.5 |
| 12:21 ET | 12977 | 5.5 |
| 12:24 ET | 2609 | 5.48 |
| 12:26 ET | 308 | 5.47 |
| 12:28 ET | 5700 | 5.47 |
| 12:30 ET | 1215 | 5.46 |
| 12:32 ET | 15753 | 5.45 |
| 12:33 ET | 1054 | 5.45 |
| 12:35 ET | 1774 | 5.4402 |
| 12:37 ET | 2996 | 5.45 |
| 12:39 ET | 200 | 5.465 |
| 12:42 ET | 200 | 5.465 |
| 12:44 ET | 859 | 5.45 |
| 12:46 ET | 2328 | 5.44 |
| 12:48 ET | 2300 | 5.45 |
| 12:51 ET | 2015 | 5.46 |
| 12:53 ET | 756 | 5.47 |
| 12:55 ET | 425 | 5.48 |
| 12:57 ET | 1051 | 5.48 |
| 01:02 ET | 1368 | 5.47 |
| 01:06 ET | 300 | 5.472526 |
| 01:08 ET | 1100 | 5.48 |
| 01:09 ET | 462 | 5.47 |
| 01:11 ET | 400 | 5.47 |
| 01:18 ET | 1427 | 5.45 |
| 01:20 ET | 400 | 5.44 |
| 01:22 ET | 4559 | 5.43 |
| 01:24 ET | 4785 | 5.4299 |
| 01:26 ET | 2763 | 5.43 |
| 01:27 ET | 500 | 5.43 |
| 01:29 ET | 2122 | 5.425 |
| 01:31 ET | 1150 | 5.4199 |
| 01:33 ET | 2922 | 5.4294 |
| 01:36 ET | 1112 | 5.43 |
| 01:38 ET | 500 | 5.43 |
| 01:40 ET | 500 | 5.425 |
| 01:42 ET | 10617 | 5.47 |
| 01:44 ET | 3282 | 5.5 |
| 01:45 ET | 2445 | 5.497 |
| 01:47 ET | 4300 | 5.51 |
| 01:49 ET | 2706 | 5.505 |
| 01:51 ET | 4622 | 5.5 |
| 01:54 ET | 9175 | 5.5 |
| 01:56 ET | 541 | 5.5004 |
| 01:58 ET | 3086 | 5.479 |
| 02:00 ET | 14985 | 5.48 |
| 02:02 ET | 12489 | 5.49 |
| 02:03 ET | 3114 | 5.51 |
| 02:05 ET | 1870 | 5.51 |
| 02:07 ET | 200 | 5.505 |
| 02:09 ET | 100 | 5.505 |
| 02:12 ET | 4273 | 5.4975 |
| 02:14 ET | 200 | 5.5 |
| 02:16 ET | 1882 | 5.49 |
| 02:18 ET | 7621 | 5.5042 |
| 02:20 ET | 895 | 5.51 |
| 02:21 ET | 300 | 5.51 |
| 02:23 ET | 700 | 5.51 |
| 02:25 ET | 100 | 5.515 |
| 02:27 ET | 200 | 5.515 |
| 02:30 ET | 2216 | 5.53 |
| 02:32 ET | 700 | 5.53 |
| 02:34 ET | 2786 | 5.54 |
| 02:36 ET | 106 | 5.54 |
| 02:38 ET | 5258 | 5.55 |
| 02:41 ET | 550 | 5.5603 |
| 02:43 ET | 100 | 5.56 |
| 02:45 ET | 3252 | 5.54 |
| 02:48 ET | 700 | 5.53 |
| 02:50 ET | 7439 | 5.54 |
| 02:52 ET | 500 | 5.54 |
| 02:54 ET | 6637 | 5.53 |
| 02:56 ET | 900 | 5.525 |
| 02:57 ET | 1109 | 5.51 |
| 02:59 ET | 300 | 5.5 |
| 03:01 ET | 3542 | 5.49 |
| 03:03 ET | 1889 | 5.47 |
| 03:06 ET | 881 | 5.46 |
| 03:08 ET | 21447 | 5.4321 |
| 03:10 ET | 1990 | 5.41 |
| 03:14 ET | 9629 | 5.4 |
| 03:15 ET | 1070 | 5.39 |
| 03:17 ET | 18451 | 5.4 |
| 03:19 ET | 11515 | 5.44 |
| 03:21 ET | 1022 | 5.44 |
| 03:24 ET | 3423 | 5.42 |
| 03:26 ET | 3300 | 5.435 |
| 03:28 ET | 2327 | 5.45 |
| 03:30 ET | 504 | 5.44 |
| 03:32 ET | 1867 | 5.44 |
| 03:33 ET | 1197 | 5.43 |
| 03:35 ET | 500 | 5.42 |
| 03:37 ET | 5211 | 5.38 |
| 03:39 ET | 700 | 5.38 |
| 03:42 ET | 930 | 5.38 |
| 03:44 ET | 3351 | 5.365 |
| 03:46 ET | 5709 | 5.3549 |
| 03:48 ET | 3600 | 5.37 |
| 03:50 ET | 3563 | 5.345 |
| 03:51 ET | 3300 | 5.355 |
| 03:53 ET | 9149 | 5.34 |
| 03:55 ET | 5583 | 5.345 |
| 03:57 ET | 11090 | 5.365 |
| 04:00 ET | 162678 | 5.37 |
Oct 30, 2024
DJ Sage Therapeutics Is Maintained at Sector Outperform by Scotiabank, from 3:01PM ET on Wednesday Oct 30, 2024 by Dow Jones
3:01PM ET on Wednesday Oct 30, 2024 by Dow JonesDJ Sage Therapeutics Price Target Cut to $26.00/Share From $52.00 by Piper Sandler, from 12:54PM ET on Wednesday Oct 30, 2024 by Dow Jones
12:54PM ET on Wednesday Oct 30, 2024 by Dow JonesDJ Sage Therapeutics Is Maintained at Perform by Oppenheimer, from 12:13PM ET on Wednesday Oct 30, 2024 by Dow Jones
12:13PM ET on Wednesday Oct 30, 2024 by Dow JonesDJ Sage Therapeutics Is Maintained at Hold by Truist Securities, from 11:47AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:47AM ET on Wednesday Oct 30, 2024 by Dow JonesDJ Sage Therapeutics Is Maintained at Neutral by HC Wainwright & Co., from 10:12AM ET on Wednesday Oct 30, 2024 by Dow Jones
10:12AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SAGE Therapeutics Inc | 350.5M | -1.0x | --- |
Personalis Inc | 335.6M | -2.6x | --- |
Codexis Inc | 328.8M | -4.3x | --- |
Nektar Therapeutics | 235.6M | -1.4x | --- |
Editas Medicine Inc | 244.3M | -1.1x | --- |
Poseida Therapeutics Inc | 318.6M | -5.1x | --- |
Company Information
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.
Contact Information
- Headquarters
- 215 1st StCAMBRIDGE, MA, United States 02142-1213
- Phone
- 617-299-8380
- Fax
- 617-299-8379
Executives
- Independent Chairman of the Board
- Geno Germano
- President, Chief Executive Officer, Director
- Barry Greene
- Principal Financial Officer, Chief Operating Officer, Principal Accounting Officer, Treasurer
- Christopher Benecchi
- Chief Medical Officer
- Laura Gault
- Director
- Jeffrey Jonas
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $350.5M |
|---|---|
Revenue (TTM) | $106.4M |
Shares Outstanding | 61.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-5.58 |
Book Value | $13.32 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -349.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
